Novel roles for cooperating collagen receptor families in fibrotic niches.

Curr Opin Cell Biol

Department of Biomedicine and Centre for Cancer Biomarkers, University of Bergen, 5009 Bergen, Norway. Electronic address:

Published: December 2023

AI Article Synopsis

  • Recent studies show that special proteins called collagen receptors work together in the tough areas around tumors, known as fibrosis or fibrotic niches.
  • In some tumors, DDR1 helps control how cancer cells interact with a collagen type called collagen III, affecting whether they stay inactive or spread to other parts of the body.
  • The study highlights the importance of understanding how these collagen receptors work together to improve treatments targeting tumors and their surrounding environments.

Article Abstract

Recent data indicate that integrin and non-integrin collagen receptors cooperate in the fibrosis-specific microenvironment (i.e., the fibrotic niche). In certain tumor types, DDR1 can regulate the interaction with collagen III to regulate dormancy and metastasis, whereas in other tumor types, DDR1 can be shed and used to reorganize collagen. DDR1 expressed on tumor cells, together with DDR2 and α11β1 integrin expressed on cancer-associated fibroblasts, can increase tumor tissue stiffness. Integrin α1β1 and α2β1 are present on immune cells where they together with the immunosuppressive collagen receptor LAIR-1 can mediate binding to intratumor collagens. In summary, collagen-binding integrins together with DDRs, can create fibrillar collagen niches that act as traps to hinder immune cell trafficking into the tumor cell mass. Binding of collagens via LAIR-1 on immune cells in turn results in CD8+T-cell exhaustion. Continued studies of these complex interactions are needed for successful new stroma-based therapeutic interventions. In the current review, we will summarize recent data on collagen receptors with a special focus on their potential role in tumor fibrosis and highlight their collaborative roles in tumor fibrotic niches.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ceb.2023.102273DOI Listing

Publication Analysis

Top Keywords

collagen receptor
8
fibrotic niches
8
collagen receptors
8
tumor types
8
types ddr1
8
immune cells
8
collagen
7
tumor
7
novel roles
4
roles cooperating
4

Similar Publications

Discoidin Domain Receptor 1 (DDR1) is a receptor tyrosine kinase that binds to and is activated by collagen(s), including collagen type I. deletion in osteoblasts and chondrocytes has previously demonstrated the importance of this receptor in bone development. In this study, we examined the effect of DDR1 ablation on bone architecture and mechanics as a function of aging.

View Article and Find Full Text PDF

Red cell microparticles produced using high-pressure extrusion enhance both primary and secondary hemostasis.

Pharmacol Rep

January 2025

Department of Neurology, Peritz Scheinberg Cerebral Vascular Disease Research Laboratories, University of Miami Miller School of Medicine, 1600 NW 10th Ave RMSB #7046, Miami, FL, 33136, USA.

Background: Current therapies to treat excessive bleeding are associated with significant complications, which may outweigh their benefits. Red blood cell-derived microparticles (RMPs) are a promising hemostatic agent. Previous studies demonstrated that they reduce bleeding in animal models, correct coagulation defects in patient blood, and have an excellent safety profile.

View Article and Find Full Text PDF

Metformin reverts aortic calcifications and elastin loss induced by an experimental metabolic syndrome.

Endocr Connect

January 2025

A McCarthy, LIOMM, Facultad de Ciencias Exactas, Universidad Nacional de la Plata, La Plata, 1900, Argentina.

Metabolic syndrome (MetS) is associated with osteogenic transdifferentiation of vascular smooth muscle cells (VSMC) and accumulation of arterial calcifications (AC). Metformin (MET) inhibits this transdifferentiation in vitro. Here, we evaluate the in vivo efficacy of oral MET to reduce AC in a model of MetS.

View Article and Find Full Text PDF

Experimental reproducibility in organ-on-chip (OOC) devices is a challenging issue, mainly caused by cell adhesion problems, as OOC devices are made of bioinert materials not suitable for natural cellularization of their surfaces. To improve cell adhesion, several surface functionalization techniques have been proposed, among which the simple use of an intermediate layer of adsorbed proteins has become the preferred one by OOC users. This way, the cells use surface receptors to adhere to the adsorbed proteins, which are in turn attached to the surface.

View Article and Find Full Text PDF

Effects of Semaglutide and Tirzepatide on Bone Metabolism in Type 2 Diabetic Mice.

Pharmaceuticals (Basel)

December 2024

Department of Endocrinology and Metabolism, Peking University People's Hospital, No.11 Xizhimen South Street, Xicheng District, Beijing 100044, China.

Type 2 diabetes and weight loss are associated with detrimental skeletal health. Incretin-based therapies (GLP-1 receptor agonists, and dual GIP/GLP-1 receptor agonists) are used clinically to treat diabetes and obesity. The potential effects of semaglutide and tirzepatide on bone metabolism in type 2 diabetic mice remain uncertain.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!